Samtidig administration af de orale antidiabetiske præparater metformin, glibenclamid og acarbose resulterede ikke i nogen klinisk relevant farmakokinetisk interaktion med rosiglitazon.
Concomitant administration with the oral anti-diabetic agents metformin, glibenclamide and acarbose did not result in any clinically relevant pharmacokinetic interactions with rosiglitazone.